LEUCI, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 1.242
EU - Europa 608
AS - Asia 434
OC - Oceania 7
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.300
Nazione #
US - Stati Uniti d'America 1.235
IT - Italia 258
CN - Cina 212
SG - Singapore 93
IE - Irlanda 76
SE - Svezia 64
DE - Germania 45
VN - Vietnam 42
FI - Finlandia 33
FR - Francia 29
PL - Polonia 22
UA - Ucraina 22
GB - Regno Unito 17
ID - Indonesia 16
KR - Corea 16
IN - India 13
TW - Taiwan 13
HK - Hong Kong 11
JP - Giappone 7
NL - Olanda 7
AU - Australia 6
CA - Canada 6
ES - Italia 6
TH - Thailandia 6
NO - Norvegia 5
BE - Belgio 4
BR - Brasile 4
PT - Portogallo 4
BA - Bosnia-Erzegovina 3
AT - Austria 2
CH - Svizzera 2
HU - Ungheria 2
IR - Iran 2
LT - Lituania 2
RU - Federazione Russa 2
TR - Turchia 2
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
EU - Europa 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SN - Senegal 1
UY - Uruguay 1
Totale 2.300
Città #
Chandler 171
Fairfield 99
Houston 86
Beijing 84
Dublin 76
Singapore 72
Ashburn 66
Torino 61
Turin 54
Woodbridge 50
Seattle 49
Jacksonville 39
Wilmington 34
Nyköping 33
Ann Arbor 28
Dong Ket 27
Cambridge 25
Pisa 22
Shanghai 22
Medford 20
Fremont 19
Princeton 19
Villeurbanne 18
Dearborn 17
Jakarta 16
Warsaw 16
Milan 15
Guangzhou 13
New York 13
Washington 13
Nanjing 11
Helsinki 10
Munich 10
Boston 9
San Diego 9
Santa Clara 9
Dallas 7
Taipei 7
Detroit 6
Florence 6
Hangzhou 6
Kunming 6
Seoul 6
Wuhan 6
A Coruña 5
Boardman 5
Pune 5
Xian 5
Chicago 4
Falls Church 4
Mountain View 4
Redwood City 4
Stavanger 4
Upper Marlboro 4
Wroclaw 4
Bangkok 3
Bengaluru 3
Boerne 3
Changsha 3
Cuneo 3
Des Moines 3
Fuzhou 3
Hebei 3
Hefei 3
Lappeenranta 3
Los Angeles 3
Luni 3
Nanchang 3
Norwalk 3
Paredes 3
Phoenix 3
Rome 3
San Francisco 3
Silver Spring 3
Tokyo 3
Weifang 3
Xizhi District 3
Zhengzhou 3
Banja Luka 2
Blackburn 2
Brescia 2
Brighton 2
Brussels 2
Cagliari 2
Campos dos Goytacazes 2
Central 2
Central District 2
Collegno 2
Columbus 2
Etobicoke 2
Formello 2
Fort Worth 2
Freehold 2
Gardone Riviera 2
Gent 2
Guiyang 2
Hanover 2
Hong Kong 2
Jinan 2
Leawood 2
Totale 1.546
Nome #
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 315
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 204
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. 156
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 150
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 149
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 141
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells. 133
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy 117
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 104
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. 85
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 84
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene 83
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks. 82
Adoptive immunotherapy against sarcomas. 79
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective 75
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. 68
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors. 66
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 59
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 55
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy 39
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 37
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers 30
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 23
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade 20
Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification 13
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification 11
Totale 2.378
Categoria #
all - tutte 8.137
article - articoli 0
book - libri 0
conference - conferenze 477
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.614


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020295 0 0 0 36 15 74 36 37 40 25 19 13
2020/2021283 13 32 18 16 20 26 8 16 20 29 24 61
2021/2022312 15 27 10 11 10 15 25 18 8 32 90 51
2022/2023535 35 42 6 63 41 122 34 46 76 17 37 16
2023/2024312 32 48 25 15 20 58 21 15 1 12 31 34
2024/2025139 17 44 57 21 0 0 0 0 0 0 0 0
Totale 2.378